TNFAIP8 promotes AML chemoresistance by activating ERK signaling pathway through interaction with Rac1

被引:0
作者
Yihua Pang
Yanan Zhao
Yan Wang
Xinlu Wang
Ruiqing Wang
Na Liu
Peng Li
Min Ji
Jingjing Ye
Tao Sun
Jingxin Li
Daoxin Ma
Fei Lu
Chunyan Ji
机构
[1] Qilu Hospital of Shandong University,Department of Hematology
[2] Taian central hospital,Department of Hematology
[3] School of Basic Medical Sciences,Department of Physiology
[4] Shandong University,undefined
来源
Journal of Experimental & Clinical Cancer Research | / 39卷
关键词
TNFAIP8; Apoptosis; Chemoresistance; ERK; Rac1; AML;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 338 条
[1]  
Wouters BJ(2016)Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia Blood 127 42-52
[2]  
Delwel R(2010)Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet Blood 115 453-474
[3]  
Dohner H(2015)Acute Myeloid Leukemia N Engl J Med 373 1136-1152
[4]  
Estey EH(2016)Diagnosis and therapy of acute myeloid leukemia in the era of molecular risk stratification Annu Rev Med 67 59-72
[5]  
Amadori S(2005)Drug therapy for acute myeloid leukemia Blood 106 1154-1163
[6]  
Appelbaum FR(2016)Thirty years of BCL-2: translating cell death discoveries into novel cancer therapies Nat Rev Cancer 16 99-109
[7]  
Buchner T(2018)The BCL-2 arbiters of apoptosis and their growing role as cancer targets Cell Death Differ 25 27-36
[8]  
Burnett AK(2018)BCL-2 family proteins: changing partners in the dance towards death Cell Death Differ 25 65-80
[9]  
Dombret H(1995)Inhibition of bcl-2 with antisense oligonucleotides induces apoptosis and increases the sensitivity of AML blasts to Ara-C Leukemia 9 131-138
[10]  
Fenaux P(2018)AMG 176, a selective MCL1 inhibitor, is effective in hematologic Cancer models alone and in combination with established therapies Cancer Discov 8 1582-1597